Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Early Inhaled Nitric Oxide for Respiratory Failure in Newborns
This study has been completed.
Study NCT00005773 Information provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
First Received: June 1, 2000 Last Updated: February 21, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypertension, Pulmonary
Respiratory Insufficiency
Infant, Newborn, Diseases
Meconium Aspiration
Pneumonia, Aspiration
Respiratory Distress Syndrome
Additional conditions recognized in this trial
Hypertension
Meconium Aspiration Syndrome
Persistent Fetal Circulation Syndrome
Pneumonia
Respiratory Distress Syndrome, Adult
Syndrome
More general conditions related to this trial
Cardiovascular Diseases
Disease
Fetal Diseases
Lung Diseases
Pathologic Processes
Pregnancy Complications
Respiration Disorders
Respiratory Tract Diseases
Respiratory Tract Infections
Vascular Diseases
Interventions listed in this trial
Inhaled Nitric Oxide
Additional drug interventions recognized in this trial
Nitric Oxide
More general drug interventions related to this trial
Anti-Asthmatic Agents
Antioxidants
Autonomic Agents
Bronchodilator Agents
Cardiovascular Agents
Endothelium-Dependent Relaxing Factors
Free Radical Scavengers
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Respiratory System Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Canadian Institutes of Health Research (CIHR)
INO Therapeutics
Back to top of Main Content
